In This Article:
SYENSQO FIRST QUARTER 2025 RESULTS
NET SALES OF €1.62 BILLION LED BY COMPOSITE MATERIALS, TECHNOLOGY SOLUTIONS & NOVECARE
RESILIENT UNDERLYING EBITDA OF €311 MILLION, UP 5% SEQUENTIALLY
FY 2025 OUTLOOK UNCHANGED
Register to the webcast scheduled at 14:00 CEST - Financial report - Financial calendar
Q1 2025 Highlights
-
Net sales of €1.6 billion were approximately flat year-on-year, due to lower volumes (-1%) while pricing remained stable; Double digit year-on-year growth in Composite Materials & Technology Solutions; On a sequential basis, net sales increased by 1%, driven by higher pricing (1%) while volumes remained stable;
-
Gross profit of €514 million decreased by 12% year-on-year, primarily driven by unfavorable mix and lower volumes, resulting in gross margin of 31.7%; On a sequential basis, gross profit increased by 7% and gross margin expanded by 160 basis points;
-
Underlying EBITDA of €311 million decreased by 15% year-on-year organically, primarily due to lower EBITDA in Specialty Polymers, partially offset by higher EBITDA in Technology solutions. On a sequential basis, underlying EBITDA increased by 5%;
-
Underlying EBITDA margin contracted by 310 basis points year-on-year, but increased by 60 basis points sequentially to 19.2%;
-
Underlying net profit of €100 million;
-
Operating cash flow of €176 million; Free cash flow of €37 million impacted by the phasing of capital expenditures;
-
Share buyback program: repurchased c. 758,000 shares, or €56 million.
Underlying (€ million) | Q1 2025 | Q1 2024 | Q4 2024 | YoY change | YoY organic | QoQ change |
Net sales | 1,619 | 1,624 | 1,598 | -0.3% | -1.4% | 1.3% |
Gross profit | 514 | 583 | 482 | -11.9% | - | 6.5% |
Gross profit margin | 31.7% | 35.9% | 30.2% | -420 bps | - | 160 bps |
Underlying EBITDA | 311 | 363 | 298 | -14.2% | -15.1% | 4.5% |
Underlying EBITDA margin | 19.2% | 22.3% | 18.6% | -310 bps | -310 bps | 60 bps |
Operating cash flow | 176 | 244 | 345 | -27.9% | - | -49.1% |
Free cash flow | 37 | 157 | 159 | n.m. | - | n.m. |
Cash conversion (LTM) | 68% | 89% | 71% | n.m. | - | n.m. |
Cash conversion (LTM) excl. €167mn payment to NJDEP in Q2'24 | 80% | 89% | 82% | -850 bps | - | -190 bps |
ROCE (LTM) | 7.1% | 9.6% | 7.9% | -250 bps | - | -80 bps |
Dr. Ilham Kadri, CEO
“The first quarter saw us deliver on our outlook, driven by double digit year-on-year revenue growth in Composite Materials and Technology Solutions as well as robust growth in Novecare. As expected, Specialty Polymers performance reflected the previously announced headwinds in Electronics; however, we continued to deliver resilient underlying margins supported by positive overall net pricing and disciplined cost control.